Morning Seminar

MS2-3

Moving beyond just ABR

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.3 (Osaka International Convention Center, 12F Conference Hall)

Chair: HIDEYUKI TAKEDANI (The University of Tokyo, IMSUT Hospital of the Institute of Medical Science, Department of Joint Surgery)

Sponsor: CSL Behring K.K.

Morning Seminar

MS2-4

Treatment strategies for chronic lymphocytic leukemia: p53 abnormalities as a critical biomarker for therapy optimization

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.4 (Osaka International Convention Center, 12F 1202)

Chair: Shinji Nakao (Department of Hematology and Pulmonary Medicine, Faculty of Medicine, Institute of Medical Pharmaceutical and Health Sciences, Kanazawa University)

Sponsor: Janssen Pharmaceutical K.K.

Morning Seminar

MS2-5

Treatment strategies for fungal infections in hematological disease

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.5 (Osaka International Convention Center, 12F Grand Toque)

Chair: Nobu Akiyama (Department of Internal Medicine, Teikyo University)

Sponsor: Astellas Pharma Inc.

Morning Seminar

MS2-6

Treatment Strategy for Lenalidomide Refractory Multiple Myeloma

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.6 (Osaka International Convention Center, 10F 1003)

Chair: Tadao Ishida (Department of Hematology, Japanese Red Cross Medical Center, Tokyo, Japan)

Sponsor: Celgene K.K.

Morning Seminar

MS2-7

Risk management of tumor lysis syndrome（TLS）

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Keita Kirito (Department of Hematology and Oncology, University of Yamanashi)

Sponsor: Sanofi K.K.

Morning Seminar

MS2-8

3rd generation TKI treatment for Ph+ALL

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.8 (Osaka International Convention Center, 10F 1002)

Chair: Isamu Sugiura (Division of Hematology and Oncology, Toyohashi Municipal Hospital)

Sponsor: Otsuka Pharmaceuticals Co., Ltd

Morning Seminar

MS2-9

Recent advances in the treatment of myelodysplastic syndromes (MDS) : The roles of transfusion and iron chelation therapy

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.9 (Osaka International Convention Center, 10F 1008)

Chair: Hiroshi Kawabata (Department of Hematology and Immunology, Kanazawa Medical University)

Sponsor: Novartis Pharma K.K.

Morning Seminar

MS2-10

Role of Nivolumab for Hodgkin Lymphoma

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.10 (Osaka International Convention Center, 10F 1009)

Chair: Junji Suzumiya (Shimane University Hospital Innovative Cancer Center)

Sponsors: ONO PHARMACEUTICAL CO., LTD./Bristol-Myers Squibb K.K.

Morning Seminar

MS2-11

Management strategy for follicular lymphoma

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.11 (Osaka International Convention Center, 10F 1004-5)

Chair: Ritsuro Suzuki (Shimane University Hospital Innovative Cancer Center)

Sponsor: Eisai Co., Ltd.

Morning Seminar

MS2-12

Treatment Strategy for Hodgkin Lymphoma

Sat. Oct 13, 2018 8:00 AM - 8:45 AM No.12 (Osaka International Convention Center, 10F 1006-7)

Chair: Kiyohiko Hatake (Department of Hematology, International University of Health and Welfare, Mita hospital)

Sponsor: Takeda Pharmaceutical Company Limited